From: Identification of clinical implications and potential prognostic models of chromatin regulator mutations in multiple myeloma
Stage
ISS + ARID
R-ISS + ARID
I
ISS stage I without ARID mutations*
R-ISS stage I without ARID mutations
II
Not stage I or stage III
III
ISS stage III with ARID mutations
R-ISS stage III with ARID mutations